Not known Factual Statements About semaglutide Week 1-6 Bundle
The trial achieved equally its Key endpoints, with semaglutide two.four mg demonstrating statistically substantial and excellent improvements in liver fibrosis without any worsening of steatohepatitis, and resolution of steatohepatitis without any worsening of liver fibrosis in people with MASH compared to placebo.1Assuming the above statement is a